For personal use only ™ E&P 4th Annual Small Cap Healthcare Conference This document contains forward -looking statements, including statements concerning Syntara's future financial position, plans, and the potential of its products and product candidates, which are based on information and assumptions available to Syntara as of the date of this document. Actual results, performance or achievements could be significantly different from those expressed in, or implied by, these forward - looking statements. A ...

Financial Data and Key Metrics Changes - Revenue for the second quarter of 2025 was $9,700,000, representing a 16.2% increase compared to $8,300,000 in the second quarter of 2024 [16] - Gross margin improved to 66.1% from 63.2% year over year, reflecting a 292 basis point increase [19] - EBITDA for the second quarter was $1,100,000, with margins expanding by 161 basis points to 11.8% from 10.2% in the prior year [20] - Net income attributable to shareholders was $1,200,000 or $0.05 per share, compared to $493,000 or $0.02 per share in the same period last year [21] Business Line Data and Key Metrics Changes - The four core verticals experienced a 27% aggregate growth year over year, with notable strength in corrections and energy [6][11] - Operating expenses increased by 18% to $5,400,000, primarily due to one-time administrative costs and the addition of key personnel [19] Market Data and Key Metrics Changes - EMEA region revenue grew by 52%, now representing 35% of total revenue, up from 27% a year ago [9][18] - North America, the largest market, saw a 29% revenue increase, driven by corrections and utilities [10] - The Asia Pacific region faced a 47% revenue decline due to a challenging year-over-year comparison [10][18] - LatAm region returned to growth with a 26% revenue increase, attributed to security modernization demand [11][17] Company Strategy and Development Direction - The company is focused on technological innovation to strengthen competitive positioning and drive growth in key verticals [12] - Plans to expand the Business Development team to support large key accounts and accelerate market share gains [14] - The strategy includes targeting critical points within non-critical infrastructure, such as hospitals and educational institutions [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model's resiliency, with continued revenue growth and margin expansion [14] - The company remains committed to differentiating itself through innovative security solutions for international customers [14] Other Important Information - The company had zero debt as of June 30, 2025, with cash and cash equivalents totaling $21,900,000 [22] Q&A Session Summary Question: Can you elaborate on the one-time expense and the border control segment? - Management indicated that the one-time administrative fees were related to consulting for finalizing processes related to the Israeli entity's redomiciliation to Canada [27] - Regarding border control, while not a main target vertical, the company is active in this sector due to current geopolitical tensions, contributing technologically to enhance safety [26]

Financial Data and Key Metrics Changes - Revenue for the second quarter of 2025 was $9.7 million, representing a 16.2% increase compared to $8.3 million in the second quarter of 2024 [16] - Gross margin improved to 66.1% from 63.2% in the prior year, reflecting a 292 basis point increase [20] - EBITDA for the second quarter was $1.1 million, up from $846,000 in the same quarter last year, with margins expanding by 161 basis points to 11.8% [21] - Net income attributable to shareholders was $1.2 million or $0.05 per share, compared to $493,000 or $0.02 per share in the prior year [22] Business Line Data and Key Metrics Changes - The four core verticals experienced a 27% aggregate growth year over year, with notable strength in energy and corrections [6] - Operating expenses increased by 18% to $5.4 million, primarily due to one-time administrative costs and the addition of key personnel [20] Market Data and Key Metrics Changes - EMEA region revenue grew by 52%, now representing 35% of total revenue, up from 27% a year ago [9][19] - North America, the largest market, saw a 29% revenue increase, driven by corrections and utilities [10] - The Asia Pacific region faced a 47% revenue decline due to a challenging year-over-year comparison and the phase-out of a large customer contract [10][19] - LatAm region returned to growth with a 26% revenue increase, attributed to successful execution of security modernization strategies [11][18] Company Strategy and Development Direction - The company is focused on technological innovation to strengthen competitive positioning and drive growth in targeted verticals [12] - Plans to expand the Business Development team to support large key accounts and accelerate market share gains [14] - The strategy includes targeting critical points within non-critical infrastructure, such as hospitals and educational institutions [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resiliency of the business model, with continued revenue growth and margin expansion [14] - The company remains committed to investing in innovative security solutions to differentiate from competitors [14] Other Important Information - The company had zero debt as of June 30, 2025, with cash and cash equivalents totaling $21.9 million [22][23] Q&A Session Summary Question: Can you elaborate on the one-time expense and the border control segment? - Management clarified that the one-time administrative fees were related to consulting fees for concluding processes related to the Israeli entity's redomiciliation to Canada [28] - The border control segment is not a main target vertical but the company is active in this sector due to current geopolitical tensions [27]

Core Viewpoint - Senstar Technologies Corporation reported strong financial results for the second quarter of 2025, highlighting revenue growth, margin expansion, and a focus on innovation in security solutions [2][3]. Financial Performance - Revenue for Q2 2025 was $9.7 million, a 16.2% increase from $8.3 million in Q2 2024 [3][9]. - Gross profit for Q2 2025 was $6.4 million, resulting in a gross margin of 66.1%, up from 63.2% in the previous year [3][9]. - Operating income increased to $1.0 million in Q2 2025 from $0.7 million in Q2 2024, driven by higher revenue and gross margin [5][9]. - Net income for Q2 2025 was $1.2 million, or $0.05 per share, compared to $0.5 million, or $0.02 per share, in the same quarter last year [6][9]. - EBITDA for Q2 2025 was $1.1 million, a 34.6% increase from $846,000 in Q2 2024 [5][9]. Operating Expenses - Operating expenses for Q2 2025 were $5.4 million, an 18% increase from $4.6 million in Q2 2024, primarily due to nonrecurring administrative costs and increased headcount [4][9]. - Research and development expenses as a percentage of revenue decreased to 9.3% in Q2 2025 from 12.8% in Q2 2024 [15]. - General and administrative expenses increased significantly by 63% year-over-year [4][15]. Cash Position - As of June 30, 2025, cash and cash equivalents, along with short-term bank deposits, totaled $21.9 million, up from $20.6 million at the end of 2024 [6][9]. - The company reported no debt as of the latest financial statement [9]. Strategic Focus - The CEO emphasized the company's commitment to innovation and strategic investments in technology to meet the growing global demand for intelligent security solutions [2]. - Senstar aims to differentiate itself through integrated hardware and software innovations, positioning itself for long-term value creation [2].

Core Insights - Senstar Technologies Corporation will report its financial results for the second quarter ended June 30, 2025, on August 25, 2025 [1] - A conference call will be held at 5:00 p.m. Eastern Time on the same day to review the financial results [1] Earnings Conference Call Information - Participants are requested to dial in 10 minutes before the conference call begins using the provided teleconferencing numbers and reference conference ID number 13754422 [2] - Toll-free dial-in number is 1-877-407-9716, and the international number is 1-201-493-6779 [3] Replay Information - A replay of the conference call will be available starting August 25, 2025, after 7:00 p.m. Eastern Time until September 8, 2025, at 11:59 p.m. Eastern Time [4] - Replay toll-free number is 1-844-512-2921, and the international number is 1-412-317-6671, with a replay pin number of 13754422 [4] Company Overview - Senstar Technologies specializes in comprehensive physical, video, and access control security products and solutions [1] - The company has been in operation for 40 years, focusing on safeguarding people, places, and property, particularly in utilities, logistics, correction facilities, and the energy market [5]

Summary of Syntara Investor Webinar Company Overview - **Company**: Syntara - **Product**: Amsulostat - **Indication**: Myelofibrosis Key Points from the Webinar FDA Guidance and Clinical Development - Syntara received FDA guidance on the clinical development of amsulostat, which was more conservative than expected, suggesting a phased approach rather than a direct transition to a pivotal study [3][6][11] - The FDA's concerns centered around the lack of control data in the ongoing phase two study, which complicates the assessment of safety and efficacy [7][11] - The proposed new pathway involves conducting a phase two b study with a control group, followed by a phase three study, which is expected to be more efficient and potentially smaller in size [8][9][10][11] - The estimated cost for the phase two b study is around $25 million, significantly lower than the previously estimated $80 million for the phase three study [20][21] Financial Position and Funding - Syntara's cash position is projected to last until the first half of 2027, extended due to the postponement of phase three activities [14][44] - The company plans to explore two funding avenues: partnering the drug and raising capital [12][22][26] - Previous successful partnerships for drugs in similar stages indicate a strong market appetite for amsulostat, despite the shift to a phase two b study [24][36] Clinical Trial Design and Patient Recruitment - The phase two b study will involve approximately 90 patients, with a focus on understanding the baseline characteristics of suboptimal patients [29][30] - The endpoints for the phase two b study will include symptom score and spleen volume [33] - The FDA has emphasized the need for clear definitions of suboptimal patients, which will be refined during the trial design process [35][46] Pipeline and Future Studies - Syntara has multiple ongoing studies, including those for myelodysplastic syndrome and skin scarring, which are funded through non-dilutive cash sources [16][39] - Results from these studies are expected to provide additional safety and efficacy data that could support the FDA review process for amsulostat [16][17] Market Reaction and Company Outlook - The market reaction to the FDA guidance was negative, reflecting disappointment over the slower development pathway [56][57] - Despite the delay, the company maintains that the clinical development pathway remains solid and recognizes the potential value of amsulostat for patients with myelofibrosis [57] Conclusion - Syntara is positioned to navigate the revised clinical development pathway for amsulostat while leveraging its other assets to maintain a robust pipeline and financial stability [57][58]

Financial Data and Key Metrics Changes - The company reported revenue of $8.4 million for Q1 2025, a 12.5% increase from $7.5 million in Q1 2024 [14] - Gross margin improved to 67.2% from 59.6% year-over-year, reflecting a 752 basis point increase [16] - EBITDA rose to $1.2 million with a margin of 14.3%, up from $114,000 and 1.5% respectively in the previous year [17] Business Line Data and Key Metrics Changes - The four core verticals experienced a 33% aggregate growth year-over-year, driven by strong performance in corrections, energy, and logistics [6][11] - Operating expenses increased by 2% year-over-year but declined to 55% of revenue from 61% in the prior year [8] Market Data and Key Metrics Changes - North America revenue increased by 6%, with Canada showing a significant 58% growth [9][14] - EMEA revenue grew by 19%, particularly strong in logistics and energy sectors [9][15] - APAC region saw a 40% revenue increase, driven by perimeter security requirements [10][15] Company Strategy and Development Direction - The company is focused on long-term growth while maintaining cost control and monitoring headcount efficiency [7] - Strategic hires were made to enhance business development in the Americas, EMEA, and APAC regions [10] - Technological innovation is prioritized, with a new product launch, Cascade Plus, aimed at scalable deployments [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to mitigate potential tariff impacts due to production strategies in Canada and the U.S. [22][23] - The company remains optimistic about capturing opportunities in LATAM despite current pressures [15] Other Important Information - Cash and cash equivalents as of March 31, 2025, were $22 million, up from $20.6 million at the end of 2024, with zero debt reported [18] Q&A Session Summary Question: Impact of tariffs on the company - Management indicated that current operations are not materially impacted by tariffs, with plans in place to mitigate potential future tariffs through U.S. assembly [22][23]

Financial Data and Key Metrics Changes - The company reported revenue of $8.4 million for Q1 2025, a 12.5% increase from $7.5 million in Q1 2024 [14] - Gross margin improved to 67.2% from 59.6% year-over-year, reflecting a 752 basis point increase [16] - EBITDA rose to $1.2 million with a margin of 14.3%, up from $114,000 and 1.5% respectively in the previous year [17] - Net income attributable to shareholders was $1 million or $0.04 per share, compared to a net loss of $746,000 or negative $0.03 per share in the prior year [17] Business Line Data and Key Metrics Changes - The four core verticals experienced a 33% aggregate growth year-over-year, contributing to overall revenue growth [6] - Notable vertical market strength was observed in energy, logistics, and corrections [7] - Operating expenses increased by 2% year-over-year but declined to 55% of revenue from 61% in the prior year [7] Market Data and Key Metrics Changes - North America revenue increased by 6%, with Canada showing a significant 58% growth [8][14] - EMEA revenue grew by 19%, driven by strong demand in logistics and energy [9][15] - APAC region saw a 40% revenue increase, attributed to perimeter security requirements in energy and logistics [10][15] - LATAM faced a decline in revenue contribution but remains a focus for future opportunities [11][15] Company Strategy and Development Direction - The company emphasizes technological innovation as a key differentiator, with a focus on the Multi sensor product line [12] - Strategic hires were made to enhance business development in the Americas, EMEA, and APAC regions [10] - The international strategy targets markets prioritizing security modernization [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to mitigate potential tariff impacts due to production primarily in Canada [22] - The company is optimistic about securing new design wins for its products, particularly in critical infrastructure [12] Other Important Information - Cash and cash equivalents as of March 31, 2025, were $22 million, up from $20.6 million at the end of 2024 [18] - The company had zero debt as of March 31, 2025 [18] Q&A Session Summary Question: Inquiry about tariff impacts - Management indicated that current operations are not materially impacted by tariffs, as most goods are produced in Canada, and plans are in place to mitigate potential future tariffs through U.S. assembly [22][23]

Core Points - Senstar Technologies Ltd. reported a net income of $1 million for the first quarter [1] - The company achieved a profit of 4 cents per share [1] - Total revenue for the period was $8.4 million [1]

Core Insights - Senstar Technologies Corporation reported strong financial results for the first quarter of 2025, highlighting double-digit revenue growth and significant improvements in gross and EBITDA margins [2][3][5]. Financial Performance - Revenue for Q1 2025 was $8.4 million, a 12.5% increase from $7.5 million in Q1 2024 [3][8]. - Gross profit reached $5.7 million, representing a gross margin of 67.2%, up from 59.6% in the previous year [3][8]. - Operating income was $1.0 million compared to an operating loss of $73,000 in the same quarter last year [5][8]. - Net income for Q1 2025 was $1.0 million, or $0.04 per share, compared to a net loss of $0.7 million, or ($0.03) per share, in Q1 2024 [5][8]. - EBITDA for the first quarter was $1.2 million, a significant increase from $114,000 in Q1 2024 [6][8]. Cost Management - Operating expenses were $4.6 million, a slight increase of 2% from $4.5 million in Q1 2024, primarily due to targeted marketing and selling expenses [4][8]. - The increase in gross margin was attributed to a balanced product mix, cost optimization, and efficient cost control [3][8]. Cash Position - As of March 31, 2025, cash and cash equivalents, along with short-term bank deposits, totaled $22 million, up from $20.6 million at the end of 2024 [6][8]. Market Position - The company experienced strong demand across its core verticals, including Corrections, Energy, and Logistics, and noted growing global interest in its MultiSensor solution [2].